Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma

NCT03139916 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Temozolomide
DRUG: Bavituximab
RADIATION: Radiation

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]